Determination of the factor V Leiden (G1691A) and prothrombin (G20210A) mutations by using a dHPLC system.

被引：0
|
作者：
van Heerde, WL
Kenis, H
Lux, P
Hamulyak, K
Wi, D
Lavergne, JMLS
Reutelingsperger, CPM
机构：
[1] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands
[2] INSERM, U143, Paris, France
[3] Univ Hosp Maastricht, Dept Haematol, Maastricht, Netherlands
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2000年 / 67卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
1337
引用
收藏
页码：245 / 245
页数：1
相关论文
共 50 条
  • [41] Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T Mutations among Sudanese Women with Recurrent Pregnancy Loss
    Babker, Asaad Ma
    Dafallah, Sarah Elsiddig
    Mohamedahmed, Khalid Abdelsamea
    Elshaikh, Rabab Hassan
    Suliman, Rania Saad
    Elzubair, Qubaa Ahmed
    Hussein, Sanaa Efatih
    Elzaki, Salaheldein G.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2024, 14 (01) : 59 - 65
  • [42] Prevalence of two thrombophilia predisposing mutations: Factor V G1691A (R506Q; Leiden) and prothrombin G20210A, among healthy Lebanese
    Tamim, H
    Finan, RR
    Almawi, WY
    THROMBOSIS AND HAEMOSTASIS, 2002, 88 (04) : 691 - 692
  • [43] Prevalence of Factor V Leiden (FVL, G1691A) and F-II (G20210A) Mutations in Jordanian Atherosclerotic Patients
    Jaradat, Ahmad Q.
    BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY, 2023, 17 (04) : 189 - 193
  • [44] Prevalence of Factor V Leiden (FVL, G1691A) and F-II (G20210A) Mutations in Jordanian Atherosclerotic Patients
    Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 2023, 17 : 189 - 193
  • [45] Large-scale screening for factor V Leiden (G1691A), prothrombin (G20210A), and MTHFR (C677T) mutations in Greek population
    Raptopoulou, Alkistis
    Michou, Vassiliki
    Mourtzi, Niki
    Papageorgiou, Efstathia G.
    Voyiatzaki, Chrysa
    Tsilivakos, Vassilis
    Beloukas, Apostolos
    Bei, Thaleia A.
    HEALTH SCIENCE REPORTS, 2022, 5 (04)
  • [46] The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with β-thalassemia major
    Al-Sweedan, Suleimman A.
    Jaradat, Said
    Iraqi, Muna
    Beshtawi, Mohamed
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (08) : 675 - 678
  • [47] Papillophlebitis associated with coexisting factor V Leiden and prothrombin G20210A mutations
    Charakidas, A
    Brouzas, D
    Andrioti, E
    Kalogeraki, A
    Koukoulomatis, P
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2002, 22 (02): : 239 - 240
  • [48] An overview of methods for detection of factor V Leiden and the prothrombin G20210A mutations
    Cooper, P. C.
    Rezende, S. M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 (03) : 153 - 162
  • [49] Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease
    Renner, W
    Köppel, H
    Brodmann, M
    Pabst, E
    Schallmoser, K
    Toplak, H
    Wascher, TC
    Pilger, E
    THROMBOSIS AND HAEMOSTASIS, 2000, 83 (01) : 20 - 22
  • [50] Combined heterozygous and homozygous factor V G1691A and prothrombin G20210A mutations as predictors of venous thrombosis during pregnancy.
    Gerhardt, A
    Zotz, RB
    Struve, S
    Scharf, RE
    BLOOD, 2001, 98 (11) : 790A - 790A
12345